ADMAL

This brand name is authorized in Nigeria.

Active ingredients

The drug ADMAL contains one active pharmaceutical ingredient (API):

1	α-β Arteether UNII WN2E3JXJ67 - .ALPHA./.BETA. ARTEETHERS
	Artemotil, also known as β-arteether, is a semi-synthetic derivative of artemisinin and a fast acting blood schizonticide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria cases.
	Read more about Artemotil

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-101294	Solution for injection	Admal Injection 150 mg/2 mL INJ_SOL 150 mg/2 mL 2 mL x 3's (in flint glass ampoules)	Oily solution for injection in 2-mL flint glass ampoule	27/05/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BE02	Artemether	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BE Artemisinin and derivatives
Discover more medicines within P01BE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-101294